The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients

Abstract

BackgroundMammography and ultrasound are the gold standard imaging techniques for preoperative assessment and for monitoring the efficacy of neoadjuvant chemotherapy in breast cancer. Maximum accuracy in predicting pathological tumor size non-invasively is critical for individualized therapy and surgical planning. We therefore aimed to assess the accuracy of tumor size measurement by ultrasound and mammography in a multicentered health services research study.MethodsWe retrospectively analyzed data from 6543 patients with unifocal, unilateral primary breast cancer. The maximum tumor diameter was measured by ultrasound and/or mammographic imaging. All measurements were compared to final tumor diameter determined by postoperative histopathological examination. We compared the precision of each imaging method across different patient subgroups as well as the method-specific accuracy in each patient subgroup.ResultsOverall, the correlation with histology was 0.61 for mammography and 0.60 for ultrasound. Both correlations were higher in pT2 cancers than in pT1 and pT3. Ultrasound as well as mammography revealed a significantly higher correlation with histology in invasive ductal compared to lobular cancers (p < 0.01). For invasive lobular cancers, the mammography showed better correlation with histology than ultrasound (p = 0.01), whereas there was no such advantage for invasive ductal cancers. Ultrasound was significantly superior for HR negative cancers (p < 0.001). HER2/neu positive cancers were also more precisely assessed by ultrasound (p < 0.001). The size of HER2/neu negative cancers could be more accurately predicted by mammography (p < 0.001).ConclusionThis multicentered health services research approach demonstrates that predicting tumor size by mammography and ultrasound provides accurate results. Biological tumor features do, however, affect the diagnostic precision.

Evaluation of circulating cell‑free DNA as a molecular monitoring tool in patients with metastatic cancer

“…A total of 15 patients with three common tumor subtypes were assessed. The majority of patients had metastatic disease at diagnosis and the median OS observed in the respective cancer subtypes was in line with previously published cohorts (42)(43)(44)(45)(46).…”

The Association Between Ultrasound Features and Biological Properties of Invasive Breast Carcinoma Is Modified by Age, Tumor Size, and the Preoperative Axilla Status

“…In the literature, it was reported that the tumor size, patient age, and nodal status were significantly associated with the biological characteristics of tumors . For instance, a tumor size larger than 2 cm was more common in human epidermal growth factor receptor 2 and triple‐negative subtypes of IBC; patients younger than 50 years showed more hormone receptor–negative cancers compared with older patients; and nodal metastases were more frequent in patients with the human epidermal growth factor receptor 2 subtype . Therefore, when evaluating the biological properties of tumors, these preoperative clinical parameters should be taken into consideration.…”

Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases

“…4c). This may be because screening mammography detects relatively small primary breast tumors (<2 cm) 45 . However, even after normalization to primary tumor age (namely ts/T), which depends on tumor size and the underlying growth parameters (Supplementary Note), breast cancer was found to disseminate later than colorectal and lung cancers ( Fig.…”